# Brazil pharmaceutical and pharmacy retail market growth

> Live situation record from CLSTR: https://clstr.news/situations/brazil-pharmaceutical-and-pharmacy-retail-market-growth
> Updated: 2026-08-21T17:46:32.000Z. Sources: 11. Developments: 2.

The Brazilian pharmaceutical and pharmacy retail market has shown significant growth through mid-2026. Total market revenue reached R$ 279.7 billion for the 12 months ending July 2026, a 13.71% increase driven largely by prescription medications, which expanded by 17.18% in revenue.

Within the pharmacy retail channel, private label brands have become an increasingly important segment. By June 2026, private label revenue reached R$ 2.98 billion, representing a 19.1% year-over-year increase and accounting for 27.2% of total pharmacy channel revenue. In self-service formats, private labels hold a 50.1% share of total brands, with growth fueled by wellness, personal care, and multivitamins.

## Timeline

### 2026-08-21: Private label brands reach R$ 2.98 billion in Brazil's pharmacy channel

Private label brands in Brazil's pharmacy channel generated R$ 2.98 billion through June 2026, marking a 19.1% year-over-year revenue increase.

3 sources. https://clstr.news/cluster/private-label-brands-reach-r-298-billion-in-brazils-pharmacy-channel

### 2026-08-19: Brazil pharmaceutical market reaches R$ 279.7 billion

Brazil's pharmaceutical market grew 13.71% to R$ 279.7 billion in the year ending July 2026, driven by prescription drugs and record sales in patented synthetics like Mounjaro.

7 sources. https://clstr.news/cluster/brazil-pharmaceutical-market-reaches-r-2797-billion

---
Cite as: Brazil pharmaceutical and pharmacy retail market growth. CLSTR, https://clstr.news/situations/brazil-pharmaceutical-and-pharmacy-retail-market-growth